Publication Bias and the Pharmaceutical Industry: The Case of Lamotrigine in Bipolar Disorder

S. Nassir Ghaemi, MD, MPH; Arshia A. Shirzadi, DO; Megan Filkowski, BA

Disclosures

Medscape J Med. 2008;10(9):211 

In This Article

Conclusions

The pharmaceutical industry is not routinely making data from negative studies available through the published scientific literature or in available Internet sources. In the case of bipolar disorder, the negative unpublished data made available on lamotrigine provide an important context for clinical practice and research.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....